Blog
An update on Insulin for Syrians
8 Feb 2017, 7:17 p.m. in Global Stories, News & Statements by Elizabeth Pfiester
Many of you supported T1International’s Insulin for Syrians campaign last year, when we raised funds for our partner organisation, the Syrian American Medical Society (SAMS) to ensure that people living with diabetes amidst the crisis in Syria would be able to have access to insulin and basic supplies. Read this update about the situation now and how your donation helped. Read more
Patients vs. Pharma: Hagens Berman files complaint against 'Big Three' insulin producers
30 Jan 2017, 9:15 p.m. in #insulin4all USA, News & Statements by T1International
The law firm Hagens Berman has filed a complaint against Eli Lilly, Novo Nordisk, and Sanofi, the ‘big three’ pharmaceutical companies that hold a near-monopoly on the insulin market. People living with type 1 diabetes will be the plaintiffs in this class action lawsuit, which alleges that Eli Lilly, Novo Nordisk and Sanofi have unjustly inflated their prices. Read more
Supporting Refugees with type 1 diabetes in Germany
23 Jan 2017, 4:51 p.m. in Global Stories by Katarina Braune
When refugees arrive in Germany and apply for asylum, the registration office and the doctors of Berlin’s refugee health department are the first people they meet. Oftentimes it is their first opportunity to see a health care professional in weeks or even months. During the past two years our health care system here in Germany has been overwhelmed by the large amount of immigrants coming to Europe. Many refugees got sick on their long and exhausting trip... Read more
T1International Year in Review: 2016
10 Jan 2017, 12:13 p.m. in News & Statements by T1International
What did T1International achieve in 2016? Lots! We raised funds to get insulin to Syrians in need, we carried out our Insulin & Supply survey to show how unaffordable type 1 diabetes really is, we launched the Type 1 Access Charter as well as the Advocacy toolkit, and so much more! Read more
Diabetes in Russia
1 Jan 2017, 3:09 p.m. in Global Stories by Hazel Hughes
Last February, I had the opportunity to leave my rural Cheshire home for a week to travel to Moscow. While there, I met with 3 women with diabetes. We shared stories and compared experiences, and my eyes were opened to the vastly different challenges that they face. Read more
Eli Lilly and Novo Nordisk: More Empty Promises
19 Dec 2016, 9:01 a.m. in #insulin4all USA, News & Statements by Elizabeth Pfiester
Outrage at soaring insulin prices in the USA has been increasing. More patients and families are speaking out against unaffordable costs for life-saving medication than ever before. In response, two of the 'Big Three' insulin makers (who control over 90% of the insulin market) have recently made moves to combat this anger. Read more
Pharmadness: Your Chance to be a Pharma Company CEO
12 Dec 2016, 11:21 a.m. in #insulin4all USA, News & Statements by Elizabeth Pfiester
Last month the Missing Medicines campaign, of which T1International is proudly a member, launched a new interactive game to illustrate the problems with the global research and development model. This experience is something that everyone should a few minutes to try. Read more
Ghana World Diabetes Day Camp
5 Dec 2016, 10:49 a.m. in Global Stories by Yaa Bimpeh
It was a very wonderful and emotional moment as we listened to the stories and life experiences that were shared. The experiences shared had a common theme about them. All those who shared their experiences stated the challenge of access to insulin and diabetes supplies. Read more
The Politics of Diabetes in Nigeria
24 Nov 2016, 9:56 a.m. in Global Stories by Olafimihan Nasiru Titilope
Support of people with diabetes and other non-communicable diseases from politicians is a common trend across the developed countries, and this has propelled them to advocate, create legislation and make policies for the education, prevention, diagnosing and management of diabetes in their respective countries. This is not the case in less-developed countries around the world... Read more
T1International Statement on ADA Insulin Price Petition
18 Nov 2016, 8:24 a.m. in #insulin4all USA, News & Statements by T1International
It is fantastic to see a large diabetes organization speaking out in this way. However, we feel that the ADA’s language around the call for price transparency does not go far enough. Read more